Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
Shuang Zhao,
No information about this author
Yunfeng Di,
No information about this author
Huilan Fan
No information about this author
et al.
Molecular Biomedicine,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Nov. 21, 2024
Abstract
Extracellular
vesicles
(EVs)
are
cell-derived
with
a
phospholipid
bilayer
measuring
50–150
nm
in
diameter
demonstrated
therapeutic
potentials.
Limitations
such
as
the
natural
biodistribution
(mainly
concentrated
liver
and
spleen)
short
plasma
half-life
of
EVs
present
significant
challenges
to
their
clinical
translation.
In
recent
years,
growing
research
indicated
that
engineered
enhanced
targeting
lesion
sites
have
markedly
promoted
efficacy.
However,
there
is
dearth
systematic
knowledge
on
advances
engineering
for
targeted
delivery.
Herein,
we
provide
an
overview
mechanisms,
techniques,
translations
applications.
Enrichment
at
may
be
achieved
through
recognition
tissue
markers,
pathological
changes,
circumvention
mononuclear
phagocyte
system
(MPS).
Alternatively,
external
stimuli,
including
magnetic
fields
ultrasound,
also
employed.
EV
techniques
fulfill
functions
includes
genetic
engineering,
membrane
fusion,
chemical
modification
physical
modification.
A
comparative
statistical
analysis
was
conducted
elucidate
discrepancies
between
diverse
size,
morphology,
stability,
efficacy
vitro
vivo.
Additionally,
summary
registered
trials
utilizing
from
2010
2023
has
been
provided,
full
discussion
perspectives.
This
review
provides
comprehensive
mechanisms
associated
delivery
applications
advocate
further
explorations
accelerate
Language: Английский
Bioengineered extracellular vesicles presenting PD-L1 and Gal-9 to ameliorate new-onset primary ovarian insufficiency (POI)
Yuanyuan Gu,
No information about this author
Guannan Zhou,
No information about this author
Menglei Zhang
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 162635 - 162635
Published: April 1, 2025
Language: Английский
Cartilage Endplate‐Targeted Engineered Exosome Releasing and Acid Neutralizing Hydrogel Reverses Intervertebral Disc Degeneration
Jiawen Zhan,
No information about this author
Yongzhi Cui,
No information about this author
Ping Zhang
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
14(2)
Published: Nov. 18, 2024
Abstract
Cartilage
endplate
cell
(CEPC)
and
nucleus
pulposus
(NPC)
inflammation
are
critical
factors
that
contribute
to
intervertebral
disc
degeneration
(IVDD).
Recent
evidence
indicated
iron
ion
influx,
reactive
oxygen
species
(ROS),
the
cGAS‐STING
pathway
involved
in
CEPC
inflammatory
degeneration.
Moreover,
cytokines
produced
by
degenerating
CEPCs
lactic
acid
accumulation
within
microenvironment
significantly
NPC
inflammation.
Consequently,
simultaneous
alleviation
of
correction
acidic
anticipated
reverse
IVDD.
Herein,
CEPC‐targeted
engineered
exosomes
loaded
with
salvianolic
A
incorporated
into
a
CaCO
3
/chitosan
hydrogel,
forming
composite
gel,
CAP‐sEXOs@Gel.
Notably,
CAP‐sEXOs@Gel
shows
long
local
retention,
realizes
slow
release
CAP‐sEXOs
specific
uptake
CEPCs.
After
CEPCs,
reduce
intracellular
ROS
inhibiting
hypoxia‐inducible
factor‐2α
(HIF‐2α)/TfR1
expression.
Iron
influx
inhibition
maintenance
normal
mitochondrial
function
reduced
mtDNA
leakage,
suppresing
pathway.
Additionally,
component
neutralizes
H
+
,
thereby
alleviating
Collectively,
this
novel
hydrogel
demonstrates
ability
concurrently
inhibit
inflammation,
presenting
promising
therapeutic
approach
for
Language: Английский